JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB312402

Alexa Fluor® 568 Anti-Transcription factor AP-2-alpha antibody [EPR2688(2)]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal Transcription factor AP-2-alpha antibody - conjugated to Alexa Fluor® 568.

View Alternative Names

AP2TF, TFAP2, TFAP2A, Transcription factor AP-2-alpha, AP2-alpha, AP-2 transcription factor, Activating enhancer-binding protein 2-alpha, Activator protein 2, AP-2

  • 578 PE

    PE Anti-Transcription factor AP-2-alpha antibody [EPR2688(2)]

  • 660 APC

    APC Anti-Transcription factor AP-2-alpha antibody [EPR2688(2)]

  • HRP

    HRP Anti-Transcription factor AP-2-alpha antibody [EPR2688(2)]

  • Alkaline Phosphatase

    Alkaline Phosphatase Anti-Transcription factor AP-2-alpha antibody [EPR2688(2)]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Transcription factor AP-2-alpha antibody [EPR2688(2)]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Transcription factor AP-2-alpha antibody [EPR2688(2)]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Transcription factor AP-2-alpha antibody [EPR2688(2)]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Transcription factor AP-2-alpha antibody [EPR2688(2)]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-Transcription factor AP-2-alpha antibody [EPR2688(2)]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR2688(2)

Isotype

IgG

Conjugation

Alexa Fluor® 568

Excitation/Emission

Ex: 578nm, Em: 603nm

Carrier free

No

Applications

Target Binding Affinity, Antibody Labelling

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Store in the dark
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Transcription factor AP-2-alpha also known as TFAP2A or AP-2 is a protein acting as an important regulator in cellular processes. It weighs approximately 52 kDa. TFAP2A is known for its role in binding specific DNA sequences to regulate target gene transcription. It expresses highly in neural crest-derived tissues as well as in the placenta breast and skin. This transcription factor plays an essential role in embryonic development cell proliferation and differentiation.
Biological function summary

TFAP2A contributes significantly to the regulation of gene expression involved in essential developmental and cellular processes. It acts as part of a complex with other transcription factors allowing it to coordinate the expression of a variety of genes linked to cell growth and apoptosis. AP-2 also regulates genes involved in neural development and skin morphogenesis. Its interaction with other factors such as AP-2γ and AP-2β enhances its functionality indicating a complex mechanism of action.

Pathways

TFAP2A engages in critical signalling circuits such as the MAPK and Wnt pathways which are essential for cell cycle regulation and embryonic development. Within these pathways related proteins like AP-2γ and AP-594 interact with TFAP2A further illustrating its role in signal transduction. These relationships highlight the importance of TFAP2A in orchestrating cellular responses to growth signals and environmental cues.

TFAP2A has links to a range of pathological conditions including cancer and neural crest-related disorders. In melanoma for example TFAP2A's regulatory role affects genes associated with tumor growth and metastasis. The protein's interaction with other transcription factors like AP-647 may influence cancer progression and therapy response. Additionally the dysregulation of TFAP2A affects neural crest development potentially leading to congenital disorders. Understanding these interactions assists in unraveling the molecular basis of such diseases and informs therapeutic strategies.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-alpha is the only AP-2 protein required for early morphogenesis of the lens vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1 promoter transcription activation. Associates with chromatin to the PITX2 P1 promoter region.
See full target information TFAP2A
style
left-column
style
left-column
style
right-column

Complementary Products

Primary Antibodies

AB2730

Anti-alpha Adaptin antibody [AP6]

Immunocytochemistry/ Immunofluorescence - Anti-alpha Adaptin antibody [AP6] (AB2730)

  • 4
  • 11
Primary Antibodies

AB321304

Alexa Fluor® 750 Anti-SMYD3 antibody [EPR11107(2)]

Recombinant|RabMAb

  • 0
  • 0
Primary Antibodies

AB138501

Anti-Alpha-synuclein antibody [MJFR1]

BOND RX™ Validated|RabMAb|Recombinant|KO Validated

Western blot - Anti-Alpha-synuclein antibody [MJFR1] (AB138501)

  • 5
  • 10
Primary Antibodies

AB155279

Anti-SOX10 antibody [EPR4007]

RabMAb|Recombinant|20ul selling size

Immunohistochemistry (Frozen sections) - Anti-SOX10 antibody [EPR4007] (AB155279)

  • 4
  • 7

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com